Skip to main content
. 2020 Aug 25;20(1):143–150. doi: 10.1007/s42000-020-00235-5

Table 1.

Patients aged ≥65 years at diagnosis

Case, gender Age at diagnosis Signs and symptoms at diagnosis that first arouse suspicion of acromegaly Basal GH (μg/L) nadir OGTT Basal IGF-1 (μg/L) Basal IGF-1 (ULN) Adenoma at diagnosis (mm) Surgery/outcome Medical treatment last control Hypopituitarism Last random GH (μg/L) Last IGF-1 (μg/L) Last IGF-1 (ULN)
1, M, 72 65 years Erectile dysfunction 6.4 447 2.14 9 Yes/remission n.a. No 0.73 200 0.97
2, M, 70 65 years Headache ➔ pituitary incidentaloma 5.9 600 2.87 10 Yes/remission n.a. No 0.11 221 0.93
3, F, 80 66 years Papillary thyroid carcinoma, obstructive sleep apnea syndrome 9.6 695 2.88 23 No SSA + CAB ?No 4.58 99 0.45
4, F, 72 67 years Carpal tunnel syndrome, mandibular overgrowth 4.76 752 3.12 11 Yes/remission n.a. TSH/ACTH 1.4 209 0.88
5, M, 72 67 years Mandibular and acral overgrowth, thyroid goiter 1.78 357 1.7 12 ?No SSA No 4.06 205 0.99
6, F, 75 68 years Profuse sweating 23 612 2.93 9 Yes/persistence SSA + GH-RA No 0.78 220 0.93
7, F, 78 68 years Papillary thyroid carcinoma, osteoporosis 6.88 1060 4.4 10 No SSA No 0.32 161 0.74
8, F, 75 68 years Carpal tunnel syndrome, acral overgrowth 2.57 314 1.3 10 No SSA + CAB No 0.68 152 0.64
9, F, 75 69 years Obstructive sleep apnea syndrome, mandibular and acral overgrowth 6.36 575 2.39 11 No SSA No 0.31 212 0.89
10, F, 82 74 years Transient ischemic attack ➔ pituitary incidentaloma 25.8 686 2.89 12 No SSA + CAB No 9.69 388 1.77
11, F, 94 75 years Mandibular and acral overgrowth 4 636 2.68 9 No SSA No 2.7 233 1.98
12, F, 83 78 years Mandibular and acral overgrowth 18.7 823 3.76 15 No SSA No 2.01 254 1.16
13, M, 88 78 years Meningioma ➔ pituitary incidentaloma 25.2 570 2.82 9 No SSA No 1.96 158 0.78